ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 879 filers reported holding ISHARES TR in Q2 2024. The put-call ratio across all filers is 4.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $321,738 | +0.0% | 2,344 | 0.0% | 0.03% | 0.0% |
Q1 2024 | $321,644 | +1.0% | 2,344 | 0.0% | 0.03% | -5.6% |
Q4 2023 | $318,433 | +11.1% | 2,344 | 0.0% | 0.04% | +2.9% |
Q3 2023 | $286,648 | -3.7% | 2,344 | 0.0% | 0.04% | 0.0% |
Q2 2023 | $297,595 | -1.7% | 2,344 | 0.0% | 0.04% | -5.4% |
Q1 2023 | $302,752 | -1.6% | 2,344 | 0.0% | 0.04% | -7.5% |
Q4 2022 | $307,744 | +12.3% | 2,344 | 0.0% | 0.04% | +5.3% |
Q3 2022 | $274,000 | -0.7% | 2,344 | 0.0% | 0.04% | 0.0% |
Q2 2022 | $276,000 | -11.5% | 2,344 | -2.1% | 0.04% | +5.6% |
Q1 2022 | $312,000 | -14.5% | 2,394 | 0.0% | 0.04% | -10.0% |
Q4 2021 | $365,000 | -5.7% | 2,394 | 0.0% | 0.04% | -11.1% |
Q3 2021 | $387,000 | -2.0% | 2,394 | -0.8% | 0.04% | -2.2% |
Q2 2021 | $395,000 | -14.5% | 2,414 | -21.4% | 0.05% | -20.7% |
Q1 2021 | $462,000 | -10.8% | 3,070 | -10.2% | 0.06% | -15.9% |
Q4 2020 | $518,000 | +11.9% | 3,418 | 0.0% | 0.07% | -5.5% |
Q3 2020 | $463,000 | -91.0% | 3,418 | -91.0% | 0.07% | -91.6% |
Q2 2020 | $5,170,000 | +58.9% | 37,825 | +25.2% | 0.86% | +23.1% |
Q1 2020 | $3,254,000 | +32.8% | 30,200 | +48.5% | 0.70% | +72.1% |
Q4 2019 | $2,450,000 | +20.2% | 20,333 | -0.8% | 0.41% | +13.3% |
Q3 2019 | $2,039,000 | +4.7% | 20,488 | +14.8% | 0.36% | +1.7% |
Q2 2019 | $1,947,000 | +1.7% | 17,850 | +4.2% | 0.35% | -1.4% |
Q1 2019 | $1,915,000 | +36.5% | 17,125 | +17.7% | 0.36% | +16.6% |
Q4 2018 | $1,403,000 | -3.6% | 14,546 | +21.9% | 0.31% | +8.5% |
Q3 2018 | $1,455,000 | +14.2% | 11,936 | +2.9% | 0.28% | +8.8% |
Q2 2018 | $1,274,000 | +3.6% | 11,598 | +0.6% | 0.26% | +2.8% |
Q1 2018 | $1,230,000 | +173.3% | 11,526 | +175.6% | 0.25% | +156.6% |
Q4 2017 | $450,000 | -3.2% | 4,182 | +205.0% | 0.10% | -8.3% |
Q3 2017 | $465,000 | +10.5% | 1,371 | +0.9% | 0.11% | +0.9% |
Q2 2017 | $421,000 | +43.7% | 1,359 | +33.4% | 0.11% | +33.8% |
Q1 2017 | $293,000 | +27.9% | 1,019 | +20.0% | 0.08% | +1.3% |
Q4 2016 | $229,000 | -10.5% | 849 | -4.3% | 0.08% | -12.2% |
Q3 2016 | $256,000 | -29.5% | 887 | -35.0% | 0.09% | -32.8% |
Q2 2016 | $363,000 | – | 1,364 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |